[Anti-recurrence treatment of patients with polyposis rhinosinusitis in initial vagotonic type of the vegetative tonus].

Transcranial electrostimulation (Transair-2) in patients with polypous rhinosinusitis having initial vagotonic type at optimal therapeutic doses 2.6-2.8 mA potentiates immunocorrective action of leukinferon. This effect was achieved due to impact on sympathetic autonomic nervous system and correction of vegetative imbalance. A persistent antirecurrence clinical effect was obtained in 22 of 23 patients with polypous rhinosinusitis accompanied with affection of the upper respiratory tract. Early recurrences of nasal polyps reduced to 4.3% in follow-up 1.5-3 years.